Vadodara: Alembic Pharma has recently announced that the Company has successfully completed
the United States Food and Drug Administration (USFDA) inspection for its
Bioequivalence Facility located at Vadodara without any observations.

The
inspection was conducted from 17th October 2022 to 21st October 2022.

Read also: Alembic Pharma gets USFDA nod for cancer injection Paclitaxel

Alembic Pharmaceuticals Limited is a vertically integrated research and development pharmaceutical company headquartered in Gujarat. It is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients with vertical integration capabilities. Products under International Generics are manufactured across our world-class facilities in Panelav, Karkhadi, and Jarod in Gujarat. Under this vertical, the company also has R&D facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (USA).

Read also: Alembic Pharma gets USFDA nod for cancer injection Paclitaxel

Leave a Reply

Your email address will not be published. Required fields are marked *